Squarepoint’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Squarepoint’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,569	Closed	-$129K	–	5067
2025 Q2	$129K	Buy	+1,569	New	+$102K	﹤0.01%	4100
2021 Q2	–	Sell	-20	Closed	-$120K	–	3739
2021 Q1	$120K	Sell	20 -131	-87%	-$950K	﹤0.01%	2859
2020 Q4	$860K	Buy	151 +139	+1,158%	+$873K	0.01%	1445
2020 Q3	$73K	Buy	+12	New	+$70K	﹤0.01%	2330
2020 Q1	–	Sell	-6	Closed	-$93K	–	2571
2019 Q4	$93K	Sell	6 -3	-33%	-$50K	﹤0.01%	2354
2019 Q3	$146K	Sell	9 -1	-10%	-$16.1K	﹤0.01%	2143
2019 Q2	$218K	Buy	10 +4	+67%	+$99K	﹤0.01%	2077
2019 Q1	$157K	Buy	6 +2	+50%	+$48K	﹤0.01%	1986
2018 Q4	$59K	Sell	4 -4	-50%	-$89.5K	﹤0.01%	1839
2018 Q3	$273K	Buy	+8	New	+$247K	﹤0.01%	1588

Other funds holding YARW

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Squarepoint's YARW Position: Q3 2025 in Review

Squarepoint sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2025, closing a stake of 1,569 shares — an estimated $129K sold.

Squarepoint first reported a position in YARW in Q3 2018 and held it in 10 quarters. The position peaked at $860K in Q4 2020. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

Squarepoint reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 1,569 Yarrow Bioscience, Inc. Common Stock shares in Q3 2025, an estimated $129K.
Squarepoint first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and held it in 10 quarters.
Squarepoint's Yarrow Bioscience, Inc. Common Stock position peaked at $860K in Q4 2020.
34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.